Organizing for innovation: towards successful translational research

被引：12

作者：

West, Will ^{[1
]}

Nightingale, Paul ^{[2
]}

机构：

[1] CellCentric, Cambridge CB10 1XL, England

[2] Univ Sussex, SPRU, Falmer BN1 9QL, England

来源：

TRENDS IN BIOTECHNOLOGY | 2009年 / 27卷 / 10期

基金：

英国工程与自然科学研究理事会;

关键词：

BIOTECH;

D O I：

10.1016/j.tibtech.2009.06.007

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The current productivity crisis in drug discovery has prompted the pharmaceutical industry to decentralize R&D, which is now more responsive, more flexible and better connected to research in academia and biotechnology firms. Organizational changes are also under way in academia. Universities are expanding their technology transfer offices and research funders are investing more in translational research. This article explains how organizational changes in industry and academia can complement each other. Successful translation of research into innovative drugs needs to take account of the increasing organizational complexity of drug discovery as the knowledge to be integrated becomes more diffuse, specialized and valuable.

引用

页码：558 / 561

页数：4

共 12 条

[1]

Bonabeau E, 2008, HARVARD BUS REV, V86, P96

[2]

CHISHOLM J, 2008, INNOVATION WEALTH NA

[3] Trapped in the 20th century? Why models of organizational learning, knowledge and capabilities do not fit bio-pharmaceuticals, and what to do about that [J].